India's Pharmaceutical Exports

Country Profile

Lebanon

Lebanon is a growing market for Indian pharmaceuticals — $43.8M in FY 2025–26, with 2.5× growth over the past decade. Medicines accounts for 52% of shipments, with vaccines contributing $3.06M. The compound annual growth rate since FY2015 stands at 8.8%.

🇱🇧 $43.8M · 2.5× growth since FY2015 · 8.8% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$43.8M
Exports FY2025–26 DGCIS
2.5×
Growth FY2015→2026
8.8%
CAGR FY2015→2026
52%
Medicines Share
5
Product Categories Supplied
Lebanon is a growing market for Indian pharmaceuticals — $43.8M in FY 2025–26, with 2.5× growth over the past decade. Medicines accounts for 52% of shipments, with vaccines contributing $3.06M. The compound annual growth rate since FY2015 stands at 8.8%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $22.8M (52.1%) Medicine Ingredients $15.0M (34.3%) Vaccines $3.06M (7.0%) Surgical & Hospital Supplies $2.72M (6.2%) Traditional & Herbal $186K (0.4%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Lebanon in the RBI overseas direct investment dataset (2011–2026).